++
For further information, see CMDT Part 22-33: Reactive Arthritis
+++
Essentials of Diagnosis
++
Oligoarthritis, conjunctivitis, urethritis, keratoderma blennorrhagicum, and mouth ulcers
Usually follows dysentery or a sexually transmitted infection
HLA-B27–positive in 50–80% of patients
+++
General Considerations
++
++
++
Most cases develop within 1–4 weeks after either a GI infection (usually with Shigella, Salmonella, Yersinia, or Campylobacter) or a sexually transmitted infection (with Chlamydia trachomatis or perhaps Ureaplasma urealyticum)
Other pathogens known to cause reactive arthritis include Mycobacterium, Streptococcus, Staphylococcus, and SARS-CoV-2
Arthritis is most commonly asymmetric and frequently involves the large weight-bearing joints (chiefly the knee and ankle)
Sacroiliitis or ankylosing spondylitis is observed in at least 20% of patients, especially after frequent recurrences
Systemic symptoms including fever and weight loss are common at the onset of disease
Mucocutaneous lesions may include
Involvement of the fingernails in reactive arthritis mimics psoriatic changes
When present, conjunctivitis is mild and occurs early in disease course
Anterior uveitis, which can develop at any time in HLA-B27-positive patients, is a more clinically significant ocular complication
Carditis and aortic regurgitation may occur
+++
Differential Diagnosis
++
++
++
++
Nonsteroidal anti-inflammatory drugs (NSAIDs) have been the mainstay of therapy
Patients who do not respond to NSAIDs may respond to the disease-modifying antirheumatic drugs (DMARDs) sulfasalazine (1 g twice daily) or methotrexate (up to 25 mg once weekly)
Anti-tumor necrosis factor agents, which are effective in other spondyloarthropathies, may have efficacy in recent-onset disease refractory to NSAIDs and DMARDs
For chronic reactive arthritis associated with chlamydial infection, ...